Literature DB >> 18346933

Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention.

Wagida A Anwar1, Hussein M Khaled, Hassan A Amra, Hani El-Nezami, Christopher A Loffredo.   

Abstract

The burden of hepatocellular carcinoma (HCC) has been increasing in Egypt with a doubling in the incidence rate in the past 10 years. This has been attributed to several biological (e.g. hepatitis B and C virus infection) and environmental factors (e.g. aflatoxin, AF). Other factors such as cigarette smoking, occupational exposure to chemicals such as pesticides, and endemic infections in the community, such as schistosomiasis, may have additional roles in the etiology or progression of the disease. Estimates of the burden of cancer caused by these factors provide an opportunity for prevention. Previously, there was strong evidence that hepatitis B virus (HBV) was the major cause of HCC in Egypt, but more recently HCV has become the predominant factor associated with the more recent epidemic of HCC. It has been well documented that Egypt has one of the highest prevalence rates of HCV infection in the world. The natural history of HCV infection and disease progression, however, are influenced by additional factors such as duration of infection, age at infection, sex, co-infection with HBV, the level of HCV viraemia and its genotype. The role of exposure to aflatoxins and development of HCC in Egypt was historically less clear. Nevertheless, recent food sampling surveys and population-based studies indicated that exposure to aflatoxins in Egypt may have been underestimated in the past. Recent results indicated that both local and imported samples were positive for aflatoxin B1 (AFB1, 17.5% and 20%, respectively), with concentrations ranging from 3 to 25 microg/kg. The level of AFB1 was dependent on the area of collection as well as the season of the year. In a population-based study, the level and frequency of aflatoxin M1 (AFM1, a major metabolite of aflatoxin B1 excreted in breast milk) was assessed as a biomarker of maternal exposure. The samples were collected from a selected group of 388 Egyptian lactating mothers during May-September 2003. Non-working status, obesity, high corn oil consumption, and the number of offspring contributed to the variability in occurrence of AFM1 in breast milk. Prevention and intervention approaches directed to risk factors of HCC can play a critical role in its prevention. In the case of HCV infection a prevention programme can be achieved by changing personal behaviors and/or cultural habits which are risk factors for HCV transmission, such as injection with contaminated syringes, blood transfusion, surgical operations, venous catheterization, use of common syringes, dental treatment and circumcision at home. Prevention of exposure to aflatoxins can be achieved either at community (via good agriculture practices) or individual levels (treatment or dietary interventions). In conclusion, due to the alarming increase in the incidence of HCC in Egypt, there is a need to further investigate the contribution of these emerging risk factors to the development of HCC in Egypt. This may enable us to determine the susceptibility to HCC among high-risk groups and to provide these individuals with effective measures for early prevention or intervention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18346933     DOI: 10.1016/j.mrrev.2008.01.005

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  48 in total

1.  Clinical profile, BRCA2 expression, and the androgen receptor CAG repeat region in Egyptian and Moroccan male breast cancer patients.

Authors:  Samuel F Gilbert; Amr S Soliman; Mehdi Karkouri; Meaghen Quinlan-Davidson; Ashley Strahley; Mohab Eissa; Subhojit Dey; Ahmed Hablas; Ibrahim A Seifeldin; Mohamed Ramadan; Noureddine Benjaafar; Kathy Toy; Sofia D Merajver
Journal:  Breast Dis       Date:  2011

2.  Epidemiologic risk factors of hepatocellular carcinoma in a rural region of Egypt.

Authors:  Amr S Soliman; Chu-Wei Hung; Alexander Tsodikov; Ibrahim A Seifeldin; Mohamed Ramadan; Dina Al-Gamal; Emily L Schiefelbein; Priyanka Thummalapally; Subhojit Dey; Kadry Ismail
Journal:  Hepatol Int       Date:  2010-08-19       Impact factor: 6.047

3.  Evaluation of annexin A2 and as potential biomarkers for hepatocellular carcinoma.

Authors:  Nevine El-Abd; Amal Fawzy; Tamer Elbaz; Sherif Hamdy
Journal:  Tumour Biol       Date:  2015-07-20

4.  Non-viral factors contributing to hepatocellular carcinoma.

Authors:  Manal A Hamed; Sanaa A Ali
Journal:  World J Hepatol       Date:  2013-06-27

Review 5.  Hepatocellular carcinoma and the risk of occupational exposure.

Authors:  Venerando Rapisarda; Carla Loreto; Michele Malaguarnera; Annalisa Ardiri; Maria Proiti; Giuseppe Rigano; Evelise Frazzetto; Maria Irene Ruggeri; Giulia Malaguarnera; Nicoletta Bertino; Mariano Malaguarnera; Vito Emanuele Catania; Isidoro Di Carlo; Adriana Toro; Emanuele Bertino; Dario Mangano; Gaetano Bertino
Journal:  World J Hepatol       Date:  2016-05-08

6.  Calligonum comosum extract inhibits diethylnitrosamine-induced hepatocarcinogenesis in rats.

Authors:  Walied Abdo; Akihiro Hirata; Mostafa Shukry; Tarek Kamal; Essam Abdel-Sattar; Engi Mahrous; Tokuma Yanai
Journal:  Oncol Lett       Date:  2015-06-03       Impact factor: 2.967

7.  Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment.

Authors:  Yan Liu; Felicia Wu
Journal:  Environ Health Perspect       Date:  2010-02-19       Impact factor: 9.031

8.  Effects of Nigella sativa on outcome of hepatitis C in Egypt.

Authors:  Eman Mahmoud Fathy Barakat; Lamia Mohamed El Wakeel; Radwa Samir Hagag
Journal:  World J Gastroenterol       Date:  2013-04-28       Impact factor: 5.742

9.  Serum IGFBP-3 is a more effective predictor than IGF-1 and IGF-2 for the development of hepatocellular carcinoma in patients with chronic HCV infection.

Authors:  Eiman Aleem; Ayman Elshayeb; Nihal Elhabachi; Amal Refaat Mansour; Ahmed Gowily; Asmaa Hela
Journal:  Oncol Lett       Date:  2011-12-30       Impact factor: 2.967

10.  Hepatitis C virus and other risk factors in hepatocellular carcinoma.

Authors:  E Schiefelbein; A-R Zekri; D W Newton; G A Soliman; M Banerjee; Ch-W Hung; I A Seifeldin; A-Ch Lo; A S Soliman
Journal:  Acta Virol       Date:  2012       Impact factor: 1.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.